← Back to Search

Treatment for Pain

Phase 4
Waitlist Available
Research Sponsored by More Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from admission date and time in pacu until discharge date and time from pacu, assessed for 12 hours after surgery
Awards & highlights

Study Summary

This trial will compare two methods of pain management to see which is better.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from admission date and time in pacu until discharge date and time from pacu, assessed for 12 hours after surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and from admission date and time in pacu until discharge date and time from pacu, assessed for 12 hours after surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Discharge location
Length of stay
Secondary outcome measures
hospital costs
morphine milligram equivalent (MME) doses
patient satisfaction
+2 more

Trial Design

2Treatment groups
Active Control
Group I: TreatmentActive Control1 Intervention
One dose of sufentanil 30 mcg sublingual will be given pre-operatively when entering the operating room and one dose post-operatively in the PACU in addition to standard of care pain management.
Group II: ControlActive Control1 Intervention
A multimodal approach to analgesia will be used in all subjects in the perioperative setting and will be used in both the control and treatment groups. Intraoperative dosing of opioids will be based on the anesthesiologist's clinical judgement related to the pain and hemodynamic response to surgical stimuli and on an as needed basis in the PACU. Administration of opioids in the PACU will be in response to moderate-to-severe pain.

Find a Location

Who is running the clinical trial?

More FoundationLead Sponsor
9 Previous Clinical Trials
876 Total Patients Enrolled
Debra Sietsema, PhDStudy DirectorMore Foundation

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any foreseeable risks associated with this curative remedy?

"With this being a Phase 4 trial, which implies that the treatment has been approved for use, our team at Power rated its safety as 3 on a 1-3 scale."

Answered by AI

Is the subject pool for this clinical trial restricted to individuals over 25?

"This trial is limited to patients aged 50 to 80, whereas there are 71 trials for minors and 247 studies targeting the geriatric population."

Answered by AI

How many participants have been enlisted in this research study?

"Yes, clinicaltrials.gov confirms that this medical research is actively recruiting. It was first posted on March 1st of 2022 and last updated on the 29th of the same month. The study needs 100 participants from a single site to participate in its data collection process."

Answered by AI

Are there opportunities to be part of this research experiment currently available?

"Affirmative. Clinicaltrials.gov has documentation suggesting that recruitment for this scientific endeavour began on March 1st 2022 and was most recently changed on the 29th of March, also in 2022. This research is hoping to acquire 100 volunteers from a single site."

Answered by AI

What goals is this experiment attempting to accomplish?

"The primary outcome this trial seeks to measure is the length of hospital stay. Secondary outcomes include any opioid-induced side effects, patient satisfaction with pain management through a 4 point Likert scale (where higher scores indicate greater satisfaction), and physical therapy performance in PACU. These metrics will be measured up to 3 days after patients' admission into the hospital."

Answered by AI

What type of individual is best suited for involvement in this experiment?

"This trial is seeking 100 individuals aged between 50 and 80, who are in some form of pain."

Answered by AI
~33 spots leftby Mar 2025